Concepedia

Publication | Closed Access

Randomized trial comparing pegylated interferon α‐2b versus pegylated interferon α‐2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients†

DOI

111

Citations

26

References

2008

Year

Montserrat Laguno, Javier Murillas, Sergio Veloso, María Larrousse, Antoni Payeras, Lucía Bonet, Francesc Vidal, Ana Milinkovic, Antoni Bassa, Concha Villalonga,
Hepatology

Abstract

In patients with HIV, HCV therapy with PEG 2b or PEG 2a plus RBV had no significant differences in efficacy and safety.

References

YearCitations

Page 1